Drugs during pregnancy and lactation : treatment options and risk assessment /: treatment options and risk assessment. (2014)

• Record Type: Book
• Further Information: Note: Edited by Christof Schaefer, Paul Peters, and Richard K. Miller.
• Editors: Schaefer, Christof; Peters, P. W. J (Paul W. J.); Miller, Richard K (Richard Kermit), 1946-
• Contents: 1. General Commentary on drug therapy and drug risks in pregnancy; 2. Specific drug therapties during pregnancy; 2.1 Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications; 2.2 Allergy and hyosensitization therapy; 2.3 Antiasthmatic and cough medication; 2.4 Nausea and vomiting in pregnancy; 2.5 Gastro-intestinal medications, hyoplipidemic agents and spasmolytics; 2.6 Anti-infective Agents; 2.7 Vaccines and immunoglobulins; 2.8 Heart and blood medications; 2.9 Anticoagulants, thrombocyte aggregation inhibitors, fibrinolyrics, and volume replacement agents; 2.10 Epilepsy and antiepileptic medications; 2.11 Psychotropic drugs; 2.12 Immunosuppression, rheumatic diseases, multiple sclerosis, and Wilson's disease; 2.13 Antineoplastic drugs; 2.14 Uterine contraction agents, tocolytics, vaginal therapeutics and local contraceptives; 2.15 Hormones; 2.16 General and local anesthetics and muscle relaxants; 2.17 Dermatological medications and local therapeutics; 2.18 Vitamins, minerals and trace elements; 2.19 Herbs during pregnancy; 2.20 Diagnostic agents; 2.21 Recreational drugs; 2.22 Poisonings and toxins; 2.23 Occupational, industrial and environmental agents; 3. General commentary on drug therapy and drug risk during lactation; 3.1 The advances of breastfeading versus the risks of maternal medication; 3.2 The passage of medication into the mother's milk; 3.3 Infant characteristics; 3.4 Milk plasma ratio; 3.5 Amount of medication in the milk and relative dose; 3.6 Toxicity of medications in the mother's milk; 3.7 Medications that affect lactation; 3.8 Breastfeeding support; 4. Specific drug therapies during lactation; 4.1 Analgesics, antiphlogistics and anesthetics; 4.2 Antiallergics, antiasthmatics and antitussives; 4.3 Gastrointestinal drugs; 4.4 Anti-infectives; 4.5 Vaccines and immunoglobulins; 4.6 Cardiovascular drugs and diuretics; 4.7 Anticoagulants, thrombocyte aggregation inhibitors and fibrinolytics; 4.8 Antiepileptics; 4.9 Psychotropic drugs; 4.10 Immunomodulating and antineoplastic agents; 4.11 Hormones and hormone antagonists; 4.12 Dermatological medication and local therapeutics; 4.13 Alternative remedies, vitamins, and minerals; 4.14 Contrast media, radionuclides and diagnostics; 4.15 Infections during breastfeeding; 4.16 Recreational drugs; 4.17 Plant toxins; 4.18 Industrial chemicals and environmental contaminants; 4.18.1 Persistent organochlorine compounds (pesticides, polychlorinated biphenyls and dioxins); 4.18.2 Mercury; 4.18.3 Lead; 4.18.4 Cadmium; 4.18.5 Other contaminants; 4.18.6 Breasfeeding despite environmental contaminants?; 4.18.7 Breastfeeding and the workplace
• Edition: Third edition
• Publisher Details: Amsterdam : Academic Press
• Publication Date: 2014
• Extent: 1 online resource
• Subjects: 618.32; Pregnant women -- Drug use; Pregnant women -- Medical care; Obstetrical pharmacology -- Handbooks, manuals, etc; Fetus -- Effect of drugs on -- Handbooks, manuals, etc; Newborn infants -- Effect of drugs on -- Handbooks, manuals, etc
• Languages: English
• ISBNs: 9780124079014
• Related ISBNs: 9780124080782
• Notes: Note: Includes bibliographical references and index.; Note: Description based on CIP data; item not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.